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Database searches can fail to detect all truly homologous sequences, particularly when dealing with
short, highly sequence diverse protein families. Here, using microtubule interacting and transport
(MIT) domains as an example, we have applied an approach of proﬁle–proﬁle matching followed
by ab initio structure modelling to the detection of true homologues in the borderline signiﬁcant
zone of database searches. Novel MIT domains were conﬁdently identiﬁed in USP54, containing
an apparently inactive ubiquitin carboxyl-terminal hydrolase domain, a katanin-like ATPase KAT-
NAL1, and an uncharacterized protein containing a VPS9 domain. As a proof of principle, we have
conﬁrmed the novel MIT annotation for USP54 by in vitro proﬁling of binding to CHMP proteins.
Structured summary:
USP8 binds: CHMPs 1A 1B 2A 2B 4C
USP54 binds: CHMPs 1B 2A 2B 4C 6
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Searches with BLAST and PSI-BLAST are generally effective for
locating homologous sequences to a query in a database [1,2].
However, some protein sequences and families offer challenges
to this established methodology [3]. These include short sequences
and families in which evolution has erased most or all traces of se-
quence similarity between descendants of a common ancestor. In
such cases, database searches may fail to assign signiﬁcant scores
to genuinely homologous sequences. Different approaches can be
taken to deal with these potential shortcomings. For example, pro-
ﬁle–proﬁle matching can be used to enhance the sensitivity of se-
quence comparisons and predicted structural features can be used
to assess the compatibility of one sequence with the fold of another
of known structure [4]. Another approach with much potential for
the ﬁltering of borderline signiﬁcant database hits is ab initio pro-
tein modelling, An increasing number of examples show that this
technique can correctly predict both familiar [5,6] and novel [7]
folds for proteins with no detectable homology to known struc-
tures. Models recapitulating known folds are often indicative of
molecular function [5,6,8], while novel fold predictions have po-
tential, for example, as an aid to phasing of crystal structures
[9,10]. Here we employ ab initio modelling in a new context, as a
ﬁlter for database search hits of borderline reliability.chemical Societies. Published by EOur chosen test case is the microtubule interacting and trans-
port (MIT) domain [11,12]. MIT domains were ﬁrst identiﬁed in
SNX15, spastin and spartin [13]. Subsequent bioinformatics analy-
sis revealed a total of 14 such domains within 12 proteins [14].
Structural determination of the N-terminal domain of the activator
of the ATPase VPS4, Vta1 further expanded the family by revealing
a tandem pair of MIT domains [15,16]. MIT domains consist of an
asymmetric 3-helix bundle that binds amphipathic helices termed
MIT-interacting motifs (MIMs) [12,16,17]. One major class of
MIM-containing proteins are a family of small molecular weight,
structurally related proteins called charged multivesicular body
proteins (CHMPs), components of the endosomal sorting complex
required for transport (ESCRT) machinery, that mediates the sort-
ing of ubiquitinated receptors to the lysosomes [12,17]. Whilst
binding to CHMPs is a biochemical signature of MIT domains,
binding proﬁles to the 11 human CHMPs vary. For example the
MIT domains of AMSH and USP8 (also known as UBPY or UBP8),
two endosomal de-ubiquitinating enzymes, have some partners
in common but only AMSH can interact with CHMP3 [14].
MIT-CHMP interactions may recruit proteins to endosomal
components and thus allow for localization of enzymatic activities
associated with MIT proteins, such as kinase (ULK3), de-ubiquiti-
nation (AMSH, USP8) or ATPase (Vps4, spastin).
MIT domains bear a structural resemblance to tetratricopeptide
repeat (TPR) and share some similarities in helix packing charac-
teristics [12]. However, the direction of the MIM helix upon inter-
action with MIT is the opposite of that present in the TPR repeatlsevier B.V. All rights reserved.
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dles could reasonably be considered as the most likely to evolve
independently, especially as helix packing angles show marked
preferences [18]. For these reasons, judgment should be reserved
on any possible evolutionary relationship between MIT and TPR
domains.
To detect novel MIT domains in the human genome we adopted
a sensitive strategy ﬁrst involving combination of sequence align-
ments based on structural alignment. Database searches with the
results yielded borderline MIT domain sequences which were then
screened in two passes, ﬁrst by proﬁle–proﬁle alignments against
entries from domain databases, and then by ab initio modelling
using ROSETTA. The combination of these proved highly effective
for distinguishing putative MIT domains from the structurally sim-
ilar TPR sequences (see above) also apparent in the results of data-
base searches. Finally, we validated one of the predicted MIT
domains by assessing its interaction in vitro with the whole com-
plement of CHMP proteins.2. Materials and methods
2.1. Bioinformatics
PSI-BLAST [1] runs in the nr database of protein sequences [19]
were carried out using sequences of known MIT domains struc-
tures – Vps4B (Protein Data Bank (PDB; [20]) code 2jqh; [17]), nu-
clear receptor binding factor 2 (NBRF2; PDB code 2crb;
unpublished) and both MIT domains from Vta1 (PDB code 2rkk;
[15]). The resulting hits were extracted using MView [21] and com-
bined on the basis of a MUSTANG [22] structural alignment of the
two MIT domains. Jalview [23] was used to adjust the combined
sequences according to the structural alignment. The resulting
large alignment was converted into a PSI-BLAST checkpoint ﬁle
using the reformat script from the HHSEARCH suite of programs
[24], and used to initiate a further iterative PSI-BLAST search of
the nr database. Surprisingly, VTA-like sequences were not re-
trieved although the combined ﬁle retrieved both Vps4-like and
NBRF-like sequences and so work progressed using results of a
structure-informed sequence alignment of PSI-BLAST hits from
Vps4B and NBRF2. (Independent experiments with the VTA-like
proﬁle did not detect any putative novel human MIT domains
(not shown).) The Vps4B+NBRF2 combined alignment checkpoint
ﬁle was again used to initiate a PSI-BLAST run in nr, to convergence
at an e-value of 0.001, and the resulting checkpoint ﬁle saved. Fi-
nally, this checkpoint (available from authors on request) was used
to scan a database containing the human sequences from UniProt
[25]. Note that only a somewhat structurally divergent MIT domain
structure, compared to Vps4B and NBRF2, is present in USP8 (PDB
code 2a9u; [26]) but this could only be uncertainly superimposed
on the other structures and hence was not included. USP8 was re-
trieved in our searches – see Section 3.
This scan of human protein sequences retrieved many known
MIT domains with signiﬁcant e-values of <1  105, but attention
was focussed on the borderline to insigniﬁcant hits with e-values
between 0.001 and 10. In order to sensitively detect MIT domains,
and weed out false positives including the structurally similar TPR
domains, we carried out local proﬁle–proﬁle matching with
HHSEARCH [24]. Each hit in this category was used to initiate a
3-iteration PSI-BLAST in the UniProt90 database (90% redun-
dancy-removed version of UniProt). The result was processed and
compared to a local database of MIT and TPR-related entries in
the Pfam domain database [27]. The MIT entries in this database
were PF04212, MIT domain; PF08969, DUF1873 (covering USP8-
like MIT domains); and PF04652, DUF605 (covering Vta1-like
MIT domains). The TPR entries included the 10 members of theTPR clan, namely PF00515, TPR_1; PF07719, TPR_2; PF07720,
TPR_3; PF07721, TPR_4; PF01535, PPR; PF08238, Sel1 PF02071,
NSF; PF07219, HemY_N; PF02184, HAT; and PF04733, Coatomer_E.
Domain composition of proteins in which novel putative MIT do-
mains were identiﬁed was analyzed using the HHpred server
([28]).
For selected results, principally longer matches of at least 60
residues, ab initio modelling was carried out using ROSETTA and
default protocols [29,30]. The sequences of the human hits were
extended to both N- and C-termini according to the respective
numbers of query residues unmatched in a rough attempt to sub-
mit a likely complete domain for modelling. 3000 models (decoys)
were obtained for each sequence and clustered according to their
structural similarity. The likely success of the modelling, expressed
as the size of the top cluster as a percentage of the number of mod-
els made, was recorded. Cluster representatives were aligned
against the PDB database using the SSM server at the EBI [31].
Matches to MIT, TPR and other domains were recorded.
2.2. Cloning of USP54
USP54-MIT was ampliﬁed from a human testis cDNA library
(Clontech, Mountain View, CA, USA) using the following primers:
USP54-MIT-forwards 50GACAAGTTTGTACAAAAAAGCAGGCTGGG
GATCCACCATGGAGAGGTCCCTGCAAGAGGCA, and USP54-MIT-re-
verse 50GACCACTTTGTACAAGAAAGCTGGGTGCTCGAGTCATGAT
TGCTGCTGCTGCATGCGAT. PCR products were cloned into the
pDONR223 vector [32], sequenced and subcloned into a pGEX6P-
GW (modiﬁed pGEX6P1) vector using the Gateway system (Invit-
rogen). GST-USP8-MIT (GST-UBPY(1–133)) has been previously
described [14], as have the yeast two-hybrid and Myc-tagged
CHMP constructs [11].
2.3. Protein expression and binding assay
GST, GST-USP8(1–133) and GST-USP54-MIT(792–868) were ex-
pressed in Rosetta (DE3) pLysS bacteria (Novagen) and puriﬁed
with glutathione sepharose (Amersham) according to the manufac-
turer’s instructions. Myc-tagged CHMP proteins were in vitro
translated using the TNT Quick Coupled Transcription/Translation
System (Promega). Ten microliters of each IVT reaction was incu-
bated with 220 pmoles of puriﬁed GST, GST-USP8(1–133), or
GST-USP54-MIT(792–868) at 4 C for an hour in 300 ll assay buffer
(20 mM Hepes pH 7.3, 120 mM KOAc, 0.1 mM DTT, 0.1% TX100,
and protease inhibitors). The samples were centrifuged to remove
precipitates. Forty microliters of glutathione sepharose beads were
added to the supernatant and incubated at room temperature for
30 min. Then the beads were washed with WB buffer (20 mM
Hepes pH 7.3, 120 mM KOAc, 0.1 mM DTT, and 0.1% TX100) for
three times and once with WB buffer without TX100. SDS–PAGE
sample buffer was added to the beads to elute proteins followed
by immunoblotting with anti-Myc and anti-GST antibodies.3. Results and discussion
3.1. Database searches
The extreme sequence diversity and short length of MIT do-
mains means that even powerful tools like PSI-BLAST cannot be
used for straightforward retrieval of all sequences: PSI-BLAST runs
initiated with Vps4B, for example, fail to retrieve Vta1-like or
NBRF2-like sequences and vice versa. More sensitive methods
were therefore adopted. These included structure-based montage
of alignments derived from different PSI-BLAST runs, and two pow-
erful techniques to screen borderline hits – proﬁle–proﬁle match-
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from PSI-BLAST runs starting from all classes of MIT domain would
have been combined. However, Ubp8 MIT was excluded since its
somewhat distorted structure could be only uncertainly aligned
with others. Since a Vps4B+NBRF2+Vta1 alignment failed to
retrieve Vta1-like sequences, Vta1 was also treated individually.
Separate experiments with Ubp8 and Vta1 did not highlight any
putative novel MIT domains (not shown). Two of the borderline
hits productively explored below – KATL1_HUMAN and
KTNA1_ HUMAN –were absent in the results of PSI-BLAST runs ini-
tiated with Vps4B or NBRF2, up to e-values of 10. This indicates the
value of working with the structure-based combination of both
Vps4B- and NBRF2-derived PSI-BLAST proﬁles.
The screen of human protein sequences with a combined proﬁle
derived from Vps4B- and NBRF2-initiated PSI-BLAST runs (Supple-
mentary ﬁle 1) retrieved prominent MIT domains such as those in
calpain and sorting nexin-15 [16] with highly signiﬁcant scores. In
the borderline to insigniﬁcant range, 0.001 < e-value < 10, 42 pro-
teins were listed (once redundancy due to alternative products
deriving from the same gene had been eliminated). These include
two known MIT domains – that of spastin [13] which achieved
an e-value of 0.005, and the domain from human USP8 (Uniprot
accession UBP8_HUMAN [26]) with an e-value of only 3.3. The
appearance of the latter so far down the hit list was a clear indica-
tion that even relatively poorly scoring sequences could potentially
be novel MIT domains. Likely false positive hits against structurally
related TPR domains were suggested by the names of some of the
proteins hit e.g. transmembrane and TPR repeat-containing protein
1 (TMTC1_HUMAN). Such proteins achieved e-values as low as
0.011 illustrating the mixture of TPR and MIT (e.g. UBP8_HUMAN)
proteins, along with diverse other false positives, in the borderline
hit zone. All remaining hits were therefore analyzed by proﬁle–
proﬁle matching against Pfam entries for MIT and TPR domains.
3.2. Proﬁle–proﬁle matching
When screened against a local database of MIT and TPR domain
alignments (see Section 2), thirteen of the proteins in the initial list
were clear TPR domains, with HHSEARCH probability values above
70 (of a maximum 100) and e-values <0.001 (Supplementary Table
1). A further 13 scored very poorly against both MIT and TPR do-
mains indicating that they were neither (Supplementary Table 2).
The best-scoring of the remaining by the initial PSI-BLAST was ‘F-
box only protein 9’ althoughmatch length was short at 32 residues.
UniProt annotates this protein as having a TPR domain, but inde-
pendent scanning at the Pfam database does not assign this do-
main. Our proﬁle–proﬁle matching gave quite signiﬁcant scores
to MIT (probability 85; e-value 8.3  105) and TPR (probability
74; e-values 0.00039) domains, marginally favouring the former.Table 1
Putative novel human MIT domain-containing proteins.
UniPROT identiﬁer (others in brackets are
isoforms deriving from the same gene)
PSI-BLAST hits using combined MIT
checkpoint ﬁle
Bit
score
e-
Value
Match
length
Match
start
Match
end
A6NI91_HUMAN 35 0.022 72 12 83
UBP54_HUMAN 30 0.47 70 794 863
KATL1_HUMAN (also A8K5X4_HUMAN,
A2A3H2_HUMAN, Q5T558_HUMAN)
29 0.91 62 10 71
KTNA1_HUMAN (also A8K7S5_HUMAN) 27 3.8 62 10 71Despite the short match length we attempted ab initio modelling
to try to resolve the ambiguity (below).
For the remaining proteins (Table 1; Fig. 1), proﬁle–proﬁle
matching unambiguously identiﬁes MIT rather than TPR domains.
The actual scores for a katanin-like protein (KATL1_HUMAN) are
not strong, but it is closely related (66% sequence identical) to a
katanin subunit (KTNA1_HUMAN) which scores strongly. Katanin
severs microtubules in an ATP-dependent manner [33], a function
probably shared by the related sequence, and also associated with
Spastin. The domain compositions of these proteins (Fig. 2) also
provide supporting evidence for the existence of MIT domains
since there are many functional connections between the addi-
tional domains and the biological contexts in which MIT domains
act. These relationships are discussed in more detail below. The
sequences in Fig. 1 share remarkably low levels of sequence iden-
tity – pairwise comparisons are in the range from 6% to 54%, mean
17%. This illustrates again how sequence diverse the MIT family is,
and offers little new support for the notion of an evolutionary rela-
tionship between MIT and TPR sequences. In particular, there are
no strongly conserved aromatic positions bridging helices, one of
the previous commented resemblances between MIT and TPR
structures [12].
3.3. Ab initio modelling
In order to provide further support for the existence of these
MIT domains we carried out ab initio structure modelling with RO-
SETTA. This has previously proved useful in our hands for verifying
suggested distant homologies [8]. For comparison, in addition to
the putative MITs, we ab initio modelled a region of ‘F-box only
protein 9’ (see above) as well as all borderline and insigniﬁcant en-
tries from our original list for which an alignment of >60 residues
was produced by PSI-BLAST (Table 2). Modelling of the ‘F-box only
protein 9’ was inconclusive: the largest cluster of ROSETTA models
accounted for only 23% of the full set, indicative of less reliable
modelling, and a representative of the top cluster bore only weak
similarity to TPR domains (not shown).
In contrast, other results (Table 2) provided strong support for
the proposed MIT domain assignments. The modelling may be
judged reliable in each case since the top cluster of independently
generated models contains a high proportion of the model set,
from 51% upwards. In all three putative MIT cases, the ab initio
modelling yielded a MIT structure: structure comparisons with
SSM to the PDB showed that representatives of the top clusters
in each case were most closely related to experimental MIT struc-
tures (Table 2, Fig. 3). In none of the three cases did TPR domains
appear in the top 40 hits showing a clear distinction between these
structures. The top ab initio model of A6NI91_HUMAN was a dis-
torted version of the MIT fold (Fig. 2), but it nevertheless matchedProtein description HHPRED
MIT
probability
HHPRED
MIT e-
value
HHPRED
TPR
probability
HHPRED
TPR e-
value
Uncharacterized protein
C16orf7
72.0 0.00048 0.1 5.9
Inactive ubiquitin
carboxyl-terminal
hydrolase 54
32.0 0.0068 0.2 5
Katanin p60 ATPase-
containing subunit A-like
1
10.5 0.041 2.4 0.27
Katanin p60 ATPase-
containing subunit A1
78.0 0.00025 3.0 0.21
Fig. 1. Sequence alignment, based on the PSI-BLAST results, of Vps4B, NBRF2 and the novel putative human MIT domains herein identiﬁed. Shading indicates sequence
conservation and the ﬁgure was produced with Jalview [23].
Fig. 2. Schematic representation, approximately to scale, of recognisable Pfam domains (boxes, labelled) in proteins containing novel putative MIT domains (ellipses). The
respective Pfam entry identiﬁers are PF00004 (AAA ATPase), PF09336 (Vps4_CT; C-terminal domain of Vps4), PF00443 (UCH; ubiquitin carboxy-terminal hydrolase), PF02204
(Vps9). Note that KTNA1_HUMAN is one residue longer than KATL1_HUMAN, has a similar sequence (66% sequence identity) and an identical domain composition.
Table 2
Ab initio structure modelling of putative MIT domains and other selected PSI-BLAST matches.
Swissprot/TrEMBL identiﬁer
(others in brackets are isoforms
deriving from the same gene)
PSI-BLAST result Protein description,
where available
Likely domain
identiﬁcation
from HHPRED
ROSETTA
largest
cluster size
(%)
ROSETTA SSMmatches
in ﬁrst 40 hits (top hit
emboldened)
Bit
score
e-
value
Match
length
Match
start
Match
end
MIT TPR Other
(where
top)
FBX9_HUMAN (also
Q59EH8_HUMAN)
35 0.020 32 92 123 F-box only protein 9 Unclear 23 – 0.21;
2avp
0.21;
1jkp
A6NI91_HUMAN 35 0.022 72 12 83 Uncharacterized protein
C16orf7
MIT 51 0.34;
2jqk
– –
OGT1_HUMAN (also
Q548W1_HUMAN)
33 0.073 55 327 388 UDP-N-acetylglucosamine–
peptide N-
acetylglucosaminyltransferase
110 kDa subunit
TPR 81 – 0.37;
2avp
–
UBP54_HUMAN 30 0.47 70 794 863 Inactive ubiquitin carboxyl-
terminal hydrolase 54
MIT 95 0.60;
2jqh
– –
KATL1_HUMAN (also
A8K5X4_HUMAN,
A2A3H2_HUMAN,
Q5T558_HUMAN)
29 0.91 62 10 71 Katanin p60 ATPase-containing
subunit A-like 1
MIT 93 0.50;
1yxr
– –
A8MZ87_HUMAN (also
A8MXL7_HUMAN)
29 1.2 63 143 205 Uncharacterized protein KLC2 TPR 92 0.31;
2v6y
0.36;
2avp
0.45;
2noj
NPHP3_HUMAN 27 4.1 74 1219 1292 Nephrocystin-3 TPR 72 – – 0.39;
2noj
IPO8_HUMAN 27 5.3 77 494 570 Importin-8 Other 23 – – 0.30;
2pmr
Z3H7B_HUMAN (also
A7YY88_HUMAN)
27 6.6 67 114 180 Zinc ﬁnger CCCH domain-
containing protein 7B
TPR 24 – – 0.15;
2caz
IFT88_HUMAN (also
Q5SZJ6_HUMAN,
A2A491_HUMAN)
26 7.2 62 589 650 Intraﬂagellar transport protein
88 homolog
TPR 38 0.32;
2v6y
0.47;
2avp
–
DNJC7_HUMAN (also
A8K4T2_HUMAN,
Q59EH7_HUMAN)
26 7.2 62 26 87 DnaJ homolog subfamily C
member 7
TPR 49 – – 0.42;
2vls
CLMN_HUMAN (also
Q6NUQ2_HUMAN,
A1A4B9_HUMAN)
26 8.1 61 235 295 Calmin Other 18 – – 0.22;
1cb1
Bold face indicates the top hits.
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Fig. 3. Pymol [42] cartoons of the superimposed structures of (a) the MIT domains from Vps4 (PDB code 2jqk; [17]) and the ROSETTA ab initio models of putative MIT
domains (see Table 1) in (b) UBP54_HUMAN, (c) KATL1_HUMAN and (d) A6NI91_HUMAN.
876 D.J. Rigden et al. / FEBS Letters 583 (2009) 872–878true MIT domains most closely among known structures. In the
two cases where neither TPR nor MIT structure was suggested by
proﬁle–proﬁle matching, the top clusters were relatively small,
indicative of less reliable modelling, and neither TPR nor MIT do-
mains appear in the top 40 hits. Modelling of likely TPR domains
was of mixed predicted success with top cluster sizes ranging from
24% to 92%, but in only two cases did the top ROSETTA model
structurally align best with true TPR domain structures. The reason
for this is most likely that by modelling sequences putatively cor-
responding to the three helices of MIT domains, ROSETTA could not
build structures that achieved (partial) matches to the four-helix
topology of paired TPR domains. However, since our interest was
in identifying MIT domains, it was reassuring and important to ob-
serve that no ab initio models of regions considered to contain
likely TPR domains resembled experimental MIT structures. This
improves conﬁdence in the accuracy of identiﬁcation of the MIT
domains listed in Table 1 and illustrated in Figs. 1 and 2.
3.4. Expression and assay of the putative USP54-MIT domain
To test the predictive power of our results we have assayed the
putative MIT domain of USP54 for CHMP binding, a common signa-
ture of MIT domain proteins. GST-USP54-MIT(792–868) was puri-
ﬁed and used to immunoprecipitate in vitro translated Myc-tagged
CHMP proteins. GST-USP8-MIT, which we have characterized pre-
viously [14], was used as a positive control. Both MIT domains
show interactions with a sub-set of CHMPs (Fig. 4). As described
previously USP8 MIT interacts with CHMPs 1A, 1B, 2A, 2B, and
4C. In relative terms, USP54 shows a weaker interaction with
CHMPs 1B, 2A and 4C but a stronger interaction with CHMP2B.
Thus, the USP54 fulﬁls the criterion of CHMP binding shared with
the majority of other MIT domains.Fig. 4. Screen of CHMP proteins for binding with GST-USP8-MIT and GST-USP54-
MIT. (A) Puriﬁed GST, GST-USP8-MIT and GST-USP54-MIT were incubated individ-
ually with in vitro translated Myc-tagged CHMP proteins at 4 C for an hour. The
proteins were isolated with glutathione sepharose and analyzed by immunoblot-
ting with anti-Myc and anti-GST antibodies. Twenty percent input was loaded as
controls. A typical GST blot is shown at the bottom as an example. (B) Quantitation
data of A that show percentage of input bound to GST-USP8-MIT and GST-USP54-
MIT. Myc-tagged CHMP2B and CHMP4C showed strong interactions with GST-
USP54-MIT.3.5. Biological implications
The novel MIT domains that we identify, one proven, the others
strongly predicted, are associated with different domain architec-
tures (Fig. 2) Among the domain combinations shown are both
familiar and novel architectures, all of which suggest functions
for the respective proteins. Thus, the katanin subunit and related
protein contain an N-terminal putative MIT domain followed by
D.J. Rigden et al. / FEBS Letters 583 (2009) 872–878 877a so-called AAA ATPase domain [34], the same architecture found
in the known MIT-containing proteins Vps4 and spastin. In com-
mon with spastin, katanin and probably the katanin-like sequence,
sever microtubules in an ATP-dependent manner [33]. Recent data
show that a non-canonical interaction between the MIT domain of
spastin and CHMP1B recruits spastin to the midbody during cyto-
kinesis [35] where it is required for abscission [36]. Given the dif-
ﬁculties of predicting MIT speciﬁcity [16], it cannot be assumed
that katanins would be similarly recruited, but the similarity of do-
main compositions suggests that this could be an interesting pos-
sibility to test. ESCRT-III recruitment of MIT proteins to both
endosomes and the mid-body is an emerging theme. Recent work
illustrates an association between BRUCE, a key regulator protein
of cytokinesis, and USP8, and also positions USP8 at the midbody
[37,38].
The existence of a MIT domain in USP54 (Uniprot accession UB-
P54_HUMAN), recalls the combination of MIT and ubiquitin C-ter-
minal hydrolase domains seen for USP8 [14,26]. However, the
USP54 catalytic domain is likely to be enzymatically inactive [39]
and may rather provide a ubiquitin binding module. The combina-
tion of MIT and Vps9 domains in the uncharacterized protein
A6NI91_HUMAN is novel. The Vps9 domain has guanine-nucleo-
tide exchange factor (GEF) activity and acts upon speciﬁc Rab GTP-
ases [40,41]. The mammalian homologue of Vps9 is rabex-5, an
exchange factor for the early endosomal rab5. This reinforces the
broad link of MIT domains with membrane trafﬁcking and
dynamics.
Taken together, the new MIT domains we identify reinforce the
emerging picture in which this domain acts to direct associated do-
mains, often with catalytic activity to particular locations within
the cell.
4. Conclusions
MIT domains possess unusual but not unique bioinformatic
challenges due to their sequence diversity and short length. Never-
theless, we have shown that screening borderline signiﬁcant and
insigniﬁcant database search hits with proﬁle–proﬁle matching
highlights previously unsuspected MIT domains. We used ab initio
modelling as a novel and effective way to improve conﬁdence in
sequence-based fold assignments and conﬁrmed the biochemical
activity of one of the newly discovered MIT domains. We further
note that the proteins accessible to current ab initio modelling,
those of up to 100–120 residues, are exactly those whose short
length may hamper databases searches. In these families in partic-
ular, our methodology could be used to extend membership.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2009.02.012.
References
[1] Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W. and
Lipman, D.J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein
database search programs. Nucleic Acids Res. 25, 3389–3402.
[2] Aravind, L. and Koonin, E.V. (1999) Gleaning non-trivial structural, functional
and evolutionary information about proteins by iterative database searches. J.
Mol. Biol. 287, 1023–1040.
[3] Koonin, E.V., Galperin, M.Y. (2003) Principles and methods of sequence
analysis, in: Sequence – Evolution – Function. Comparative Approaches in
Comparative Genomics. Anonymous. Kluwer Academic Publishers, Boston/
Dordrecht/London, pp. 111–192.
[4] Dunbrack Jr., R.L. (2006) Sequence comparison and protein structure
prediction. Curr. Opin. Struct. Biol. 16, 374–384.
[5] Bonneau, R., Strauss, C.E., Rohl, C.A., Chivian, D., Bradley, P., Malmstrom, L.,
Robertson, T. and Baker, D. (2002) De novo prediction of three-dimensional
structures for major protein families. J. Mol. Biol. 322, 65–78.[6] Malmstrom, L., Rifﬂe, M., Strauss, C.E., Chivian, D., Davis, T.N., Bonneau, R. and
Baker, D. (2007) Superfamily assignments for the yeast proteome through
integration of structure prediction with the gene ontology. PLoS Biol. 5, e76.
[7] Das, R., Qian, B., Raman, S., Vernon, R., Thompson, J., Bradley, P., Khare, S., Tyka,
M.D., Bhat, D., Chivian, D., Kim, D.E., Shefﬂer, W.H., Malmstrom, L., Wollacott,
A.M., Wang, C., Andre, I. and Baker, D. (2007) Structure prediction for CASP7
targets using extensive all-atom reﬁnement with Rosetta@home. Proteins 69
(Suppl. 8), 118–128.
[8] Rigden, D.J. and Galperin, M.Y. (2008) Sequence analysis of GerM and SpoVS,
uncharacterised bacterial ‘sporulation’ proteins with widespread phylogenetic
distribution. Bioinformatics 24, 1793–1797.
[9] Qian, B., Raman, S., Das, R., Bradley, P., McCoy, A.J., Read, R.J. and Baker, D.
(2007) High-resolution structure prediction and the crystallographic phase
problem. Nature 450, 259–264.
[10] Rigden, D.J., Keegan, R.M. and Winn, M.D. (2008) Molecular replacement using
ab initio polyalanine models generated with ROSETTA. Acta Crystallogr. D Biol.
Crystallogr. 64, 1288–1291.
[11] Tsang, H.T., Connell, J.W., Brown, S.E., Thompson, A., Reid, E. and Sanderson,
C.M. (2006) A systematic analysis of human CHMP protein interactions:
additional MIT domain-containing proteins bind to multiple components of
the human ESCRT-III complex. Genomics 88, 333–346.
[12] Scott, A., Gaspar, J., Stuchell-Brereton, M.D., Alam, S.L., Skalicky, J.J. and
Sundquist, W.I. (2005) Structure and ESCRT-III protein interactions of the MIT
domain of human VPS4A. Proc. Natl. Acad. Sci. USA 102, 13813–13818.
[13] Ciccarelli, F.D., Proukakis, C., Patel, H., Cross, H., Azam, S., Patton, M.A., Bork, P.
and Crosby, A.H. (2003) The identiﬁcation of a conserved domain in both
spartin and spastin, mutated in hereditary spastic paraplegia. Genomics 81,
437–441.
[14] Row, P.E., Liu, H., Hayes, S., Welchman, R., Charalabous, P., Hofmann, K.,
Clague, M.J., Sanderson, C.M. and Urbe, S. (2007) The MIT domain of UBPY
constitutes a CHMP binding and endosomal localization signal required for
efﬁcient epidermal growth factor receptor degradation. J. Biol. Chem. 282,
30929–30937.
[15] Xiao, J., Xia, H., Zhou, J., Azmi, I.F., Davies, B.A., Katzmann, D.J. and Xu, Z. (2008)
Structural basis of Vta1 function in the multivesicular body sorting pathway.
Dev. Cell. 14, 37–49.
[16] Hurley, J.H. and Yang, D. (2008) MIT domainia. Dev. Cell. 14, 6–8.
[17] Stuchell-Brereton, M.D., Skalicky, J.J., Kieffer, C., Karren, M.A., Ghaffarian, S.
and Sundquist, W.I. (2007) ESCRT-III recognition by VPS4 ATPases. Nature 449,
740–744.
[18] Trovato, A. and Seno, F. (2004) A new perspective on analysis of helix–helix
packing preferences in globular proteins. Proteins 55, 1014–1022.
[19] Wheeler, D.L., Barrett, T., Benson, D.A., Bryant, S.H., Canese, K., Chetvernin, V.,
Church, D.M., DiCuccio, M., Edgar, R., Federhen, S., Geer, L.Y., Kapustin, Y.,
Khovayko, O., Landsman, D., Lipman, D.J., Madden, T.L., Maglott, D.R., Ostell, J.,
Miller, V., Pruitt, K.D., Schuler, G.D., Sequeira, E., Sherry, S.T., Sirotkin, K.,
Souvorov, A., Starchenko, G., Tatusov, R.L., Tatusova, T.A., Wagner, L. and
Yaschenko, E. (2007) Database resources of the National Center for
Biotechnology Information. Nucleic Acids Res. 35, D5–D12.
[20] Berman, H., Henrick, K., Nakamura, H. and Markley, J.L. (2007) The worldwide
Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data.
Nucleic Acids Res. 35, D301–D303.
[21] Brown, N.P., Leroy, C. and Sander, C. (1998) MView: a web-compatible
database search or multiple alignment viewer. Bioinformatics 14, 380–381.
[22] Konagurthu, A.S., Whisstock, J.C., Stuckey, P.J. and Lesk, A.M. (2006)
MUSTANG: a multiple structural alignment algorithm. Proteins 64, 559–574.
[23] Clamp, M., Cuff, J., Searle, S.M. and Barton, G.J. (2004) The Jalview Java
alignment editor. Bioinformatics 20, 426–427.
[24] Soding, J. (2005) Protein homology detection by HMM–HMM comparison.
Bioinformatics 21, 951–960.
[25] Consortium, UniProt (2008) The universal protein resource (UniProt). Nucleic
Acids Res. 36, D190–D195.
[26] Avvakumov, G.V., Walker, J.R., Xue, S., Finerty Jr, P.J., Mackenzie, F., Newman,
E.M. and Dhe-Paganon, S. (2006) Amino-terminal dimerization, NRDP1-
rhodanese interaction, and inhibited catalytic domain conformation of the
ubiquitin-speciﬁc protease 8 (USP8). J. Biol. Chem. 281, 38061–38070.
[27] Finn, R.D., Mistry, J., Schuster-Bockler, B., Grifﬁths-Jones, S., Hollich, V.,
Lassmann, T., Moxon, S., Marshall, M., Khanna, A., Durbin, R., Eddy, S.R.,
Sonnhammer, E.L. and Bateman, A. (2006) Pfam: clans, web tools and services.
Nucleic Acids Res. 34, D247–D251.
[28] Soding, J., Biegert, A. and Lupas, A.N. (2005) The HHpred interactive server for
protein homology detection and structure prediction. Nucleic Acids Res. 33,
W244–W248.
[29] Simons, K.T., Kooperberg, C., Huang, E. and Baker, D. (1997) Assembly of
protein tertiary structures from fragments with similar local sequences using
simulated annealing and Bayesian scoring functions. J. Mol. Biol. 268, 209–
225.
[30] Simons, K.T., Ruczinski, I., Kooperberg, C., Fox, B.A., Bystroff, C. and Baker, D.
(1999) Improved recognition of native-like protein structures using a
combination of sequence-dependent and sequence-independent features of
proteins. Proteins 34, 82–95.
[31] Krissinel, E. and Henrick, K. (2004) Secondary-structure matching (SSM), a
new tool for fast protein structure alignment in three dimensions. Acta
Crystallogr. D Biol. Crystallogr. 60, 2256–2268.
[32] Rual, J.F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N.,
Berriz, G.F., Gibbons, F.D., Dreze, M., Ayivi-Guedehoussou, N., Klitgord, N.,
878 D.J. Rigden et al. / FEBS Letters 583 (2009) 872–878Simon, B.F., Boxem, M., Milstein, S., Rosenberg, J., Goldberg, D.S., Zhang, L.V.,
Wong, S.L., Franklin, G., Li, S., Albala, J.S., Lim, J., Fraughton, C., Llamosas, E.,
Cevik, S., Bex, C., Lamesch, P., Sikorski, R.S., Vandenhaute, J., Zoghbi, H.Y.,
Smolyar, A., Bosak, S., Sequerra, R., Doucette-Stamm, L., Cusick, M.E., Hill, D.E.,
Roth, F.P. and Vidal, M. (2006) Towards a proteome-scale map of the human
protein–protein interaction network. Nature 437, 1173–1178.
[33] McNally, F.J. and Thomas, S. (1998) Katanin is responsible for the M-
phase microtubule-severing activity in Xenopus eggs. Mol. Biol. Cell 9,
1847–1861.
[34] Neuwald, A.F., Aravind, L., Spouge, J.L. and Koonin, E.V. (1999) AAA+: a class of
chaperone-like ATPases associated with the assembly, operation, and
disassembly of protein complexes. Genome Res. 9, 27–43.
[35] Yang, D., Rismanchi, N., Renvoise, B., Lippincott-Schwartz, J., Blackstone, C. and
Hurley, J.H. (2008) Structural basis for midbody targeting of spastin by the
ESCRT-III protein CHMP1B. Nat. Struct. Mol. Biol. 15, 1278–1286.
[36] Connell, J.W., Lindon, C., Luzio, J.P. and Reid, E. (2009) Spastin couples
microtubule severing to membrane trafﬁc in completion of cytokinesis and
secretion. Trafﬁc 10, 42–56.[37] Pohl, C. and Jentsch, S. (2008) Final stages of cytokinesis and midbody ring
formation are controlled by BRUCE. Cell 132, 832–845.
[38] Mukai, A., Mizuno, E., Kobayashi, K., Matsumoto, M., Nakayama, K.I., Kitamura,
N. and Komada, M. (2008) Dynamic regulation of ubiquitylation and
deubiquitylation at the central spindle during cytokinesis. J. Cell. Sci. 121,
1325–1333.
[39] Quesada, V., Diaz-Perales, A., Gutierrez-Fernandez, A., Garabaya, C., Cal, S. and
Lopez-Otin, C. (2004) Cloning and enzymatic analysis of 22 novel human
ubiquitin-speciﬁc proteases. Biochem. Biophys. Res. Commun. 314, 54–62.
[40] Esters, H., Alexandrov, K., Iakovenko, A., Ivanova, T., Thoma, N., Rybin, V.,
Zerial, M., Scheidig, A.J. and Goody, R.S. (2001) Vps9, Rabex-5 and DSS4:
proteins with weak but distinct nucleotide-exchange activities for Rab
proteins. J. Mol. Biol. 310, 141–156.
[41] Carney, D.S., Davies, B.A. and Horazdovsky, B.F. (2006) Vps9 domain-
containing proteins: activators of Rab5 GTPases from yeast to neurons.
Trends Cell Biol. 16, 27–35.
[42] DeLano, W.L. (2002) The PyMOL Molecular Graphics System on the World
Wide Web <http://www.pymol.org>.
